Centiva Capital’s NEVRO CORP. NVRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-23,462
Closed -$131K 2547
2024
Q3
$131K Sell
23,462
-20,063
-46% -$140K ﹤0.01% 1930
2024
Q2
$366K Buy
43,525
+30,490
+234% +$325K 0.01% 1353
2024
Q1
$188K Buy
+13,035
New +$216K ﹤0.01% 1496
2023
Q4
Sell
-13,514
Closed -$260K 2321
2023
Q3
$260K Buy
+13,514
New +$288K 0.01% 1253
2020
Q4
Sell
-2,645
Closed -$368K 1141
2020
Q3
$368K Buy
+2,645
New +$353K 0.02% 429

Other funds holding NVRO

Centiva Capital's NVRO Position: Q4 2024 in Review

Centiva Capital sold out of NEVRO CORP. (NVRO) in Q4 2024, closing a stake of 23,462 shares — an estimated $131K sold.

Centiva Capital first reported a position in NVRO in Q3 2020 and held it in 5 quarters. The position peaked at $368K in Q3 2020. 129 funds tracked by Wall St. Rank hold NVRO as of Q4 2024.

  • Centiva Capital reported no remaining NEVRO CORP. position as of Q4 2024 after selling out during the quarter.
  • Centiva Capital sold 23,462 NEVRO CORP. shares in Q4 2024, an estimated $131K.
  • Centiva Capital first reported a position in NEVRO CORP. in Q3 2020 and held it in 5 quarters.
  • Centiva Capital's NEVRO CORP. position peaked at $368K in Q3 2020.
  • 129 funds tracked by Wall St. Rank held NEVRO CORP. as of Q4 2024.

Based on Centiva Capital's 13F filing for Q4 2024, filed 14 Feb 2025.